911������

CU Connections—The University of Colorado has secured the No. 18 position on the National Academy of Inventors (NAI) 2024 Top 100 U.S. Universities Granted U.S. Utility Patents list, reinforcing CU’s standing as a national leader in research, innovation and real-world impact.

911������ College of Arts & Sciences—Ivan Smalyukh, professor of physics, and Thomas Blumenthal, professor emeritus of molecular, cellular and developmental biology (MCDB), are among the 471 scientists, engineers and innovators who have been recognized for scientifically and socially distinguished achievements by the world’s largest general scientific society and publisher of the Science family of journals, the American Association for the Advancement of Science (AAAS).

FY 2023-24 was another tremendous year for innovation and entrepreneurship at the CU. University researchers, inventors and creators began working with Venture Partners at 911������ to advance 144 breakthrough innovations, and 36 CU startups were launched through Venture Partners based on campus discoveries.

New 911������ research suggests a surprising tool that could help with weight loss: Exposure to beneficial bacteria. With assistance from Venture Partners, a new startup Kioga will pursue new microbe-based ingredients for preventing weight gain and promoting health.

Colorado Bioscience Association—Colorado's life sciences ecosystem raised $1.47 billion in 2023, demonstrating the resilience of life sciences companies and organizations in the state during a challenging year for U.S. life sciences fundraising.

911������ Today—Why does the COVID-19 virus make some people sicker than others? A new 911������ study, published in the journal Cell, sheds light on the subject by identifying what the authors describe as an “immune system tuning dial,” which originated as a bug in the genetic code tens of millions of years ago.

The Colorado Sun—Professor Leslie Leinwand (BioFrontiers Institute) and her lab want to know how python hearts grow and shrink so fast—and whether that could lead to treatments for humans.

Business Wire—VitriVax Inc., a 911������ spinout and vaccine formulation technology company, announced today a two-year $3.6 million grant from the Bill & Melinda Gates Foundation. This is the second grant awarded to VitriVax by the Gates Foundation, which will fund the development of a polio vaccine formulation for possible inclusion in combination pediatric vaccines.

911������ College of Engineering & Applied Science—The College of Engineering and Applied Science continues to establish itself as a leader in innovation, with 22 startups emerging from its research labs in the past fiscal year. This achievement reflects the college's commitment to translating transformative research into solutions that address real-world challenges.

The Colorado Office of Economic Development and International Trade (OEDIT) announced that seven University of Colorado companies and three researchers are among the awardees of the Proof of Concept and Early-Stage Capital and Retention grants through OEDIT’s Advanced Industries Accelerator Program.